Loading...
| A06129 | Pages: 205 | Apr 2020 | 2941 Views | | |
| Author(s) : Sanjivan Gill | Tables: 85 | Charts: 28 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Direct Fed Microbial Market
Request Now !The global direct fed microbial market was valued at $980 million in 2018, and is expected to reach $1,772million by 2026, registering a CAGR of 7.5% from 2019 to 2026.
Microbes are defined as microscopic living organisms which occur in nature as single celled organisms or colony of cells. Some microbes are harmful to human and animal health, whereas as some are highly beneficial for both humans and animals. Therefore, microbes which are supplemented orally to produce benefits in animals are called as direct-fed microbes. Furthermore, this use of microbes as feed supplement exhibits positive impact on the immune response, overall health, and performance of livestock. In addition, some of the direct fed microbial products available in the direct fed microbial market contain specifically selected strains of bacteria,which have the abilities to produce high levels of beneficial enzymes such as alpha amylase, cellulase, and protease. Furthermore, these products are used in various types of animals such as swine, poultry, ruminants, and aquatic animals.
Get more information on this report : Request Sample Pages
Major factors driving the market growth include increase indemand for meat & milk consumption and rise inprofitability at same cost. Surge in human population and increase in demand for proteinous diet boost the market growth of direct-fed microbial. For instance, human population is increasing at a rate of 1.1% annually. This growth in the population is expected to increase the consumption of animal products such as meat and milk. For example, the consumption of meat has tripled over the last four decades. Furthermore, in the developed countries such as the U.S., the UK, and Germany, the consumption of meat per personis fairly high. Thus, these factors boost the direct fed microbial market growth. 8In addition, probiotics aids nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increase the profitability of the animal producers. However, stringent regulations set regarding the vigorous usage of these microorganisms in animal diet and increase incost of production are the major factors hampering the market growth. On the contrary, ban on the usage of antibiotics in animal diet in developed nations such the U.S., Germany, and the UK and rise in animal health concerns are some of the major factors expected to providelucrative opportunities for direct fed microbial market expansion in the near future.
The direct fed microbial market size is studied on the basis ofproduct type, livestock, and region. By product type, the market is bifurcated into lactic acid bacteria, bacillus, and other organisms. Dependingon livestock, the market is classified into swine, poultry, ruminants, aquatic animals, and other livestock animals. Region wise, itisanalyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).
By product, the lactobacillus segment accounted for more than half the share of total market in 2018, and is expected to exhibit a prominent growth rate in the near future, owing to its increased usage in the livestock diet. Furthermore, Lactobacillus species is the most widely used probiotics in the livestock diet, as it is considered safe and more beneficial as compared to the other bacterial species.In addition, the other benefits offered by the bacillusdirect fed microbial include improved normal digestion, and improved nutritional value of the feed as Bacillus strains produce vitamins and essential amino acids. Furthermore, other benefits include reduction in hepatic total cholesterol, plasma low-density lipoprotein cholesterol, and triglycerides, which promote better health in animals. Thus, all these factors are anticipated to fuel the direct fed microbial market growth in near future.
Get more information on this report : Request Sample Pages
By livestock, the poultry segment acquired the major direct fed microbial market size in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the fact that poultry is the most consumed animal meat across the globe. Furthermore, individuals prefer poultry other than other livestock animals, which boosts the market growth.
Get more information on this report : Request Sample Pages
By region, North America accounted for the major direct fed microbial market share in 2018, and is expected tocontinue this trend,owing to easy availability of direct fed microbial products. Moreover, surge in the demand for probiotics and rise in awareness toward maintenance of healthy lifestyle in the region are the major reason that contribute to the growth of this market. However, Asia-Pacific is expectedto register the fastest growth during the forecast period attributedto increasein awareness regarding the use of direct-fed microbial.
Get more information on this report : Request Sample Pages
The global direct fed microbial market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Koninklijke DSM N. V, Bio-Vet, Archer-Daniels-Midland Company, CHR. Hansen A/S, E. I. Du Pont De Nemours And Company, Novozymes A/S, Kemin Industries, Inc., BASF SE (BASF Corporation), Evonik Industries Ag, and Adisseo.
Key Benefits For Stakeholders
This report entails a detailed quantitative analysis along with the current global direct fed microbial market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
The direct fed microbial market forecast is studied from 2019 to 2026.
The direct fed microbial market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the direct fed microbial market
Key Market Segments
By Product Type
By Livestock
By Region
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Top player positioning
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in demand for meat and milk
3.4.1.2.High need for probiotics to save cost
3.4.2.Restraints
3.4.2.1.Increase in cost of production
3.4.3.Opportunity
3.4.3.1.Rise in concerns regarding the use of antibiotics in animals
CHAPTER 4:DIRECT FED MICROBIAL MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast, by type
4.2.Lactic acid bacteria
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Bacillus
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:DIRECT FED MICROBIAL MARKET, BY LIVESTOCK
5.1.Overview
5.1.1.Market size and forecast, by livestock
5.2.Swine5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Poultry
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Ruminants
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Aquatic animals
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:DIRECT FED MICROBIAL MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by livestock
6.2.4.Market size and forecast, by country
6.2.4.1.U.S. market size and forecast, by type
6.2.4.2.U.S. market size and forecast, by livestock
6.2.4.3.Canada market size and forecast, by type
6.2.4.4.Canada market size and forecast, by livestock
6.2.4.5.Mexico market size and forecast, by type
6.2.4.6.Mexico market size and forecast, by livestock
6.3.Europe6.3.1.Key market trends and opportunities
6.3.2.Europe market size and forecast, by type
6.3.3.Europe market size and forecast, by livestock
6.3.4.Europe market size and forecast, by country
6.3.4.1.France market size and forecast, by type
6.3.4.2.France market size and forecast, by livestock
6.3.4.3.UK market size and forecast, by type
6.3.4.4.UK market size and forecast, by livestock
6.3.4.5.Germany market size and forecast, by type
6.3.4.6.Germany market size and forecast, by livestock
6.3.4.7.Spain market size and forecast, by type
6.3.4.8.Spain market size and forecast, by livestock
6.3.4.9.Rest of Europe market size and forecast, by type
6.3.4.10.Rest of Europe market size and forecast, by livestock
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Asia-Pacific market size and forecast, by type
6.4.3.Asia-Pacific market size and forecast, by livestock
6.4.4.Asia-Pacific market size and forecast, by country
6.4.4.1.Japan market size and forecast, by type
6.4.4.2.Japan market size and forecast, by livestock
6.4.4.3.China market size and forecast, by type
6.4.4.4.China market size and forecast, by livestock
6.4.4.5.India market size and forecast, by type
6.4.4.6.India market size and forecast, by livestock
6.4.4.7.Australia market size and forecast, by type
6.4.4.8.Australia market size and forecast, by livestock
6.4.4.9.Rest of Asia-Pacific market size and forecast, by type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by livestock
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.LAMEA market size and forecast, by type
6.5.3.LAMEA market size and forecast, by livestock
6.5.4.LAMEA market size and forecast, by country
6.5.4.1.Brazil market size and forecast, by type
6.5.4.2.Brazil market size and forecast, by livestock
6.5.4.3.Saudi Arabia market size and forecast, by type
6.5.4.4.Saudi Arabia market size and forecast, by livestock
6.5.4.5.Rest of LAMEA market size and forecast, by type
6.5.4.6.Rest of LAMEA market size and forecast, by livestock
6.5.4.7.Rest of LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.ADISSEO
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.2.ARCHER-DANIELS-MIDLAND COMPANY
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.3.BASF SE (BASF Corporation)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.BIO-VET
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.5.CHR. HANSEN A/S
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.5.4.Business performance
7.6.E. I. DU PONT DE NEMOURS AND COMPANY
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.EVONIK INDUSTRIES AG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.9.KEMIN INDUSTRIES, INC.
7.9.1.Company overview
7.9.2.Operating business segments
7.9.3.Product portfolio
7.10.KONINKLIJKE DSM N. V.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.11.Novozymes A/S
7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Business performance
LIST OF TABLES
TABLE 01.GLOBAL DIRECT FED MICROBIAL MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 02.DIRECT FED MICROBIAL MARKET FOR LACTIC ACID BACTERIA, BY REGION, 2018–2026 ($MILLION)
TABLE 03.DIRECT FED MICROBIAL MARKET FOR LACTIC ACID BACTERIA, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04.DIRECT FED MICROBIAL MARKET FOR BACILLUS SUBTILIS, BY REGION 2018–2026 ($MILLION)
TABLE 05.DIRECT FED MICROBIAL MARKET FOR BACILLUS SUBTILIS, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06.DIRECT FED MICROBIAL MARKET FOR OTHERS, BY REGION 2018–2026 ($MILLION)
TABLE 07.DIRECT FED MICROBIAL MARKET FOR BACILLUS, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08.GLOBAL DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 09.DIRECT FED MICROBIAL MARKET FOR SWINE, BY REGION, 2018–2026 ($MILLION)
TABLE 10.DIRECT FED MICROBIAL MARKET FOR POULTRY, BY REGION, 2018–2026 ($MILLION)
TABLE 11.DIRECT FED MICROBIAL MARKET FOR RUMINANTS, BY REGION, 2018–2026 ($MILLION)
TABLE 12.DIRECT FED MICROBIAL MARKET FOR AQUATIC ANIMALS, BY REGION, 2018–2026 ($MILLION)
TABLE 13.DIRECT FED MICROBIAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY REGION, 2018–2026 ($MILLION)
TABLE 14.DIRECT FED MICROBIAL MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 17.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 18.U.S. DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 19.U.S. DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 20.CANADA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 21.CANADA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 22.MEXICO DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 23.MEXICO DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 24.EUROPE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25.EUROPE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 26.EUROPE DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27.FRANCE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 28.FRANCE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 29.UK DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 30.UK DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 31.GERMANY DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 32.GERMANY DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 33.SPAIN DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 34.SPAIN DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 35.REST OF EUROPE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 36.REST OF EUROPE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 37.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 39.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 40.JAPAN DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 41.JAPAN DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 42.CHINA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 43.CHINA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 44.INDIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 45.INDIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 46.AUSTRALIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 47.AUSTRALIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 50.LAMEA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51.LAMEA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 52.LAMEA DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 53.BRAZIL DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 54.BRAZIL DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 55.SAUDI ARABIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 56.SAUDI ARABIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 57.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 58.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 59.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 60.ADISSEO: COMPANY SNAPSHOT
TABLE 61.SUZHOU ZHONGJING LIFE & SCIENCE TECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
TABLE 62.ARCHER DANIELS: COMPANY SNAPSHOT
TABLE 63.ARCHER DANIELS: OPERATING SEGMENTS
TABLE 64.ARCHER DANIELS: PRODUCT PORTFOLIO
TABLE 65.BASF: COMPANY SNAPSHOT
TABLE 66.BASF: OPERATING SEGMENTS
TABLE 67.BASF: PRODUCT PORTFOLIO
TABLE 68.BIO-VET: COMPANY SNAPSHOT
TABLE 69.BIO-VET: PRODUCT PORTFOLIO
TABLE 70.CHR. HANSEN.: COMPANY SNAPSHOT
TABLE 71.CHR. HANSEN.: OPERATING SEGMENTS
TABLE 72.CHR. HANSEN.: PRODUCT PORTFOLIO
TABLE 73.DUPONT: COMPANY SNAPSHOT
TABLE 74.DUPONT: OPERATING SEGMENTS
TABLE 75.DUPONT: PRODUCT PORTFOLIO
TABLE 76.EVONIK.: COMPANY SNAPSHOT
TABLE 77.EVONIK.: PRODUCT PORTFOLIO
TABLE 78.KEMIN: COMPANY SNAPSHOT
TABLE 79.KEMIN: PRODUCT PORTFOLIO
TABLE 80.KONINKLIJKE DSM: COMPANY SNAPSHOT
TABLE 81.KONINKLIJKE DSM: OPERATING SEGMENTS
TABLE 82.KONINKLIJKE DSM: PRODUCT PORTFOLIO
TABLE 83.NOVOZYMES A/S: COMPANY SNAPSHOT
TABLE 84.NOVOZYMES A/S: PRODUCT CATEGORIES
TABLE 85.NOVOZYMES A/S: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL DIRECT FED MICROBIAL MARKET SEGMENTATION
FIGURE 02.HIGH-TO-MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW THREAT OF SUBSTITUTES
FIGURE 05.LOW THREAT OF NEW ENTRANTS
FIGURE 06.HIGH COMPETITIVE RIVALARY
FIGURE 07.TOP PLAYER POSITIONING, 2018
FIGURE 08.DRIVERS AND RESTRAINTS
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR SWINE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR POULTRY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR RUMINANTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.BASF: NET SALES, 2016–2018 ($MILLION)
FIGURE 15.BASF: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 16.BASF: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 17.CHR. HANSEN: NET SALES, 2017–2018 ($MILLION)
FIGURE 18.CHR. HANSEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 19.CHR. HANSEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 20.NET SALES, 2016–2018 ($MILLION)
FIGURE 21.DUPONT: NET SALES BY DIVISION, 2018 (%)
FIGURE 22.DUPONT: NET SALES BY REGION, 2018 (%)
FIGURE 23.KONINKLIJKE DSM: NET SALES, 2017–2018 ($MILLION)
FIGURE 24.KONINKLIJKE DSM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 25.KONINKLIJKE DSM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 26.NOVOZYMES A/S: REVENUE, 2016–2018 ($MILLION)
FIGURE 27.NOVOZYMES A/S: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.NOVOZYMES A/S: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
The administration of probiotics helps to increase the animal feed efficiency and improves the balance of gut microflora. These probiotic microbial strains help to break down the complex substances consumed by the animal, converting them into simple compounds. These simple compounds can easily be used for energy conversion by the animals thereby improving the nutrient absorption in the animals. This helps to increase the production of meat and milk in ruminant animals, which, in turn, benefits animal producers. Moreover, probiotic microbes help to modulate the immune response in animals. This helps to reduce the probability of animals being affected by different diseases, increasing their mortality rate and improving the quality of animals produced. Although the cost of direct-fed microbial products are high, the use of these products are cost-effective for the animal producers.
A. The total market value of direct fed microbials market is $980.1 million in 2018.
A. The forcast period for direct fed microbials market is 2019 to 2026
A. The market value of direct fed microbials market in 2019 is $1,066.30 million.
A. The base year is 2018 in direct fed microbials market
A. Top companies such as, Chr. Hansen A/S, Du Pont, Koninklijke DSM N. V. and Archer-Daniels-Midland Company held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Bacillus segment is the most influencing segment owing to its benefits as a direct fed microbial. For insatnce, it promotes normal digestion, help to improve the nutritional value of feed, reduce hepatic total cholesterol and others.
A. The major factor that fuels the growth of the global direct fed microbials market includes rise in demand for meat and milk. This leads to surge in demand for direct fed microbials devices which contribute to the growth of the market.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 8.7%. This is due to surge in awareness related to use of direct fed microbials, rise in awareness related to animal health and increase in disposable income.
A. Direct-fed microbial or probiotics are live microorganisms that are beneficial to the gut health. These probiotics are included in the diet of animals to promote their growth and development
A. The direct fed microbials help to boost the immune system of animals, and thus prevent the growth of pathogenic organisms in the gut. The use of probiotic organisms is replacing antibiotic usage to enhance the health and performance of livestock animals
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
